Delivery Order SPE2DB24D3014-SPE2DB25FKUGT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,504.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pen injectors on July 22, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml). This firm fixed-price, competitively awarded contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and is...
- The Defense Logistics Agency awarded a $12,054.36 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injectors on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,041.04 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 30, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,143.52 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL dosage). This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pen injectors with a firm fixed price ceiling value of $2,644.53 and an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026 that supports global...
- The Defense Logistics Agency awarded a $1,986.80 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for pharmaceutical supply to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $4,166.35 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract utilizes a non-set-aside procurement vehicle and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child order under a larger contract mechanism, this delivery order represents a single...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,408.41 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pen injectors on a firm fixed-price basis. This non-set-aside award was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical delivery. The order represents a single transaction within the company's...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKUGTDelivery Order
The Defense Logistics Agency (DLA) awarded a $4,413.01 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 11, 2025, with completion scheduled for August 12, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within the pharmaceutical distribution portfolio that AmerisourceBergen maintains with the federal government. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies critical medications and medical commodities to support military and veteran healthcare systems. Trulicity is a diabetes medication commonly used within the Defense Health Agency's pharmaceutical formulary, and this delivery order fulfills an immediate supply need for federal medical programs. The contract reflects AmerisourceBergen's capability to compete successfully in open market procurement and its role as a key vendor in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/11/25 |